Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000015

CEO gave up 17,566 shares (to pay taxes)

  • CEO acquired 116,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doshi Dipal · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-01 Grant or award : show line 1 in the form +116,200 441,953 D
2025-03-03 Shares withheld for taxes : show line 2 in the form −17,566 $11.68 $205,146 424,387 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +173,400 173,400 D
Loading xslF345X05/wk-form4_1741125701.xml…